Match Document Document Title
7427398 Mammalian animal composition  
The present invention relates to the use of probiotic microorganism in the manufacture of a composition for the prevention or reduction of gastrointestinal Campylobacter infection in a mammalian...
7390519 Probiotic Lactobacillus salivarius strains  
A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially undesirable...
7384628 Lactic acid bacteria and its use in direct-fed microbials  
A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis, and Lactobacillus brevis. The composition is suitable for...
7381406 Probiotic lactobacillus strains for pets  
The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce...
7374924 Use of selected lactic acid bacteria for reducing infantile colic  
The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for...
7358083 Food-grade cloning vector and their use in lactic acid bacteria  
Novel food-grade cloning vectors comprising a nonsense mutation suppressor-encoding gene, which vector, when it is present in a lactic acid bacterial strain, permits such a strain to have an...
7354757 Lactobacillus brevis strain  
Lactobacillus strains that have a genetic Profile I based on Apa I, Not I, and Xba I digests are provided. Preferably, the strains decrease level of at least one of coliforms and E. coli within...
7351572 Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy  
The present invention provides an isolated microorganism strain, Lactobacillus fermentum GM-090, which is found to be effective in stimulating IFN-γ secretion and/or treating allergy. The use of...
7329741 Polynucleotides that hybridize to DP-75 and their use  
The present invention is a novel nucleic acid sequence which hybridizes to SEQ ID NO:6 or fragments thereof under stringent conditions, or fragments thereof. The invention also includes diagnostic...
7326558 Process for treating spirulina  
The treatment of spirulina by a process which includes placing spirulina that has not been previously heat-sterilized, lactic acid bacteria and sugar in water, then culturing the lactic acid...
RE40023 Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use  
A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition...
7312067 Lactic acid producing bacteria for use as probiotic organisms in the human vagina  
The present invention discloses novel isolated strains of lactic acid producing bacteria of the genera Lactobacillus and Pediococcus, and a method for isolation of such bacterial strains, having...
7300787 Lactobacillus strains and use thereof in fermentation for L-lactic acid production  
The present invention relates to L-lactic acid producing bacterial strains, including Lactobacilli such as NRRL B-30568 (ADM B64), NRRL B-30569 (ADM DEC2-2B), NRRL B-30570 (ADM RP1A-4E), NRRL...
7282354 Method for producing fermented milk product  
There is provided a fermented milk product that contains lactic acid bacteria capable of producing a large amount of lactotripeptide and a large amount of active ingredient having hypotensive...
7270994 Lactobacillus casei Bd-II stain and used to reduce blood cholesterol  
The invention disclosed a kind of lactobacillus casei Bd-II, the accession number of the deposit of which is CGMCC NO.0849, and also disclosed a use of it for reducing blood lipid level. Further,...
7244424 Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic  
The strain of micro-organism Lactobacillus fermentum ME-3 is a novel anti-microbial and anti-oxidative probiotic. It has a high anti-microbial effect on Escherichia coli, Shigella sonnei,...
7241441 Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities  
The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune...
7238351 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it  
The method of producing a microbial adherence inhibitor for administration to food animals to control the incidents of acidosis in food animals by preventing the adherence of colony-forming lactic...
7235395 Lactic acid bacteria as agents for treating and preventing allergy  
The present invention pertains to novel strains of lactic acid bacteria capable of reducing an individual's tendency to react allergic against a variety of different allergens. In particular, the...
7202219 Use of D-tagatose as a prebiotic food component  
Oral intake of D-tagatose in a prebiotic food induces production of butyrate and stimulates the growth of beneficial bacteria in the human colon. Therefore it is believed to be useful in food or...
7195906 Bifidobacterium in the treatment of inflammatory disease  
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the...
7192581 Lactobacillus reuteri useful as probiotics  
The present invention relates to a Lactobacillus reuteri variant from animal sources that inhibits rotavirus infection and other pathogenic microorganisms, as well as being tolerant of gastric and...
7189390 Probiotics for pet food applications  
The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood...
7186545 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom  
A strain of Lactobacillus salivarius isolated from resected and washed human gastrointestinal tract inhibits a broad range of Gram positive and Gram negative microorganisms and secretes a product...
7183101 NCC2705—the genome of a bifidobacterium  
A novel microorganism of the genus Bifidobacterium longum, in particular to its genomic and plasmid sequence and to a method of producing polypeptides of said Bifidobacterium, respectively. Also...
7183108 Selection and uses of lactic acid bacteria strains modulating non-specific immunity  
The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said...
7172777 Powder for preparation of a probiotic yogurt food  
The invention relates to a powder for preparation of a probiotic yogurt food. The powder contains probiotic cultures with a prespecified proportion of living probiotic lactic-acid bacteria and a...
7169911 AbiZ phage resistance gene  
A first aspect of the present invention is an isolated nucleic acid encoding a phage abortive defense protein, the isolated nucleic acid selected from the group consisting of: (a) isolated nucleic...
7150986 Lactic acid bacteria-containing probiotics products  
The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous...
7147847 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria  
Disclosed is the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions containing such bacteria....
7138113 Glycoprotein matrix compositions and methods related thereto  
A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The...
7125708 Composition comprising a Lactobacillus pentosus strain and uses thereof  
A novel probiotic strain termed Lactobacillus pentosus NCIMB 41114 is capable of preventing growth of pathogenic microorganisms in the GI tract. In particular, this bacterium inhibits Candida...
7122370 Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life  
Disclosed is a formulation for preserving the life of probiotic bacteria during passage through the stomach, while permitting their release in the intestine, and which has a low water activity and...
7112322 Probiotics in primary prevention of atopic diseases  
The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bacteria, beneficial microbes of the...
7105336 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter  
Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains,...
7067300 Process for the biological production of 1,3-propanediol with high titer  
The present invention provides an improved method for the biological production of 1,3-propanediol from a fermentable carbon source in a single microorganism. In one aspect of the present...
7063836 Compositions and methods for inhibiting pathogenic growth  
The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises...
7052688 Method for prevention and/or treatment of infections and inflammatory conditions using a combination of lactic acid bacteria  
The disclosure is of a combination of lactic acid bacteria comprising: (a) a first component consisting of at least one strain of H2O2-producing lactic acid bacteria; and (b) a second component...
7037708 Dried microorganism cultures and method for producing same  
Dry microorganism cultures comprising at least one microorganism species in carrier-bound form are present in the form of particles which a) have a particle size of at least about 0.1 mm and b)...
7029670 Medicines for relieving intestinal disorders  
An agent for relieving intestinal disorders which contain live cells of a strain belonging to Lactobacillus helveticus. This strain is preferably characterized by a resistance to a specific bile...
7026161 Lactobacillus sp. strain and use thereof  
The present invention relates a novel Lactobacillus sp. strain and use thereof. More specifically, the present invention relates to a novel Lactobacillus sp. strain, Lactobacillus paracasei,...
7025974 Absorbent product containing absorbent structure and bacillus coagulans  
The invention describes compositions and methods for inhibiting microbial infections associated with the use of sanitary products, such as diapers, bandages, sanitary napkins, tampons and the...
7011826 Control of acidosis  
The present invention relates to a vaccine for the prevention of lactic acidosis in a vertebrate, said vaccine comprising at least one isolated microorganism, or fragment or fragments thereof,...
7001756 Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity  
The present invention provides an isolated microorganism strain, Lactobacillus rhamnosus GM-020, which is found to be effective in treating obesity and a complication thereof. The use of the...
6994987 Process for producing tripeptides  
A process for efficiently, easily and stably producing tripeptides Val-Pro-Pro and Ile-Pro-Pro, which are useful as hypotensive drugs, anti-stress drugs, etc., by an enzymatic method. This process...
6994997 Gram positive bacteria deprived of HtrA protease activity and their uses  
The invention concerns bacteria strains, obtained from gram-positive bacteria whereof the genome size is not more than 3.2 Mb, and wherein the HtrA surface protease is inactive. Said strains are...
6994848 Lactobacillus paracasei strain GM-080 for treating allergy related diseases  
The present invention provides an isolated microorganism strain, Lactobacillus paracasei GM-080, which is found to be effective in treating allergy. The use of the Lactobacillus paracasei GM-080...
6960465 Increased cell resistance to toxic organic substances  
Recombinant microorganisms and related methods of use to enhance tolerance to toxic substances. In particular, such microorganisms and methods can be used to increase solvent production.
6953574 Method for producing a fermented hydrolyzed medium containing microorganisms  
A method of producing a hydrolyzed fermented medium containing microorganisms includes providing at least one solid plant product reduced to small pieces and mixed with sugar and biocompatible...
6942849 Incorporation of exogenous lactic bacteria into the oral microflora  
The present invention provides compositions for the prophylaxis or treatment of dental caries, dental plaque, and periodontal infection that include lactic bacteria that are not part of the...